Riddhi Siddhi Gluco Biols files SEBI Reg 29(2) disclosure for Vital Connections LLP

What Riddhi Siddhi Gluco Biols announced

Riddhi Siddhi Gluco Biols Ltd (BSE: 524480) submitted a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing, made on 25 June 2026, relates to an acquisition of shares in Vital Connections LLP.

The notice was lodged with the Bombay Stock Exchange, satisfying the statutory requirement to inform the market when a party acquires a substantial shareholding in a target entity.

Regulation 29(2) disclosure details

Regulation 29(2) mandates that any person or entity acquiring shares that cross the 25 % threshold of a listed company’s share capital must disclose the acquisition to the stock exchange within two working days. While the filing confirms that the acquisition qualifies as ‘substantial’, it does not provide specifics such as:

• Number of shares acquired
• Percentage of total share capital represented by the acquisition
• Consideration paid or any related agreements

The absence of these details is typical for an initial Reg 29(2) notice, which primarily serves to alert the market and trigger any required procedural steps under the SEBI takeover code.

Target entity – Vital Connections LLP

Vital Connections LLP is identified as the target of the share acquisition. No additional information about the LLP’s business, valuation, or relationship with Riddhi Siddhi Gluco Biols is disclosed in the filing. The LLP is not a listed entity, and therefore the acquisition does not automatically trigger a full takeover offer under SEBI rules, but the Reg 29(2) filing ensures regulatory transparency.

Key facts at a glance

Why this matters for investors

The Reg 29(2) filing signals that Riddhi Siddhi Gluco Biols is expanding its stake in an external business entity. While the immediate financial impact cannot be quantified from the notice, the disclosure fulfills a regulatory checkpoint that protects minority shareholders by ensuring that substantial share movements are publicly recorded. Investors should monitor subsequent filings for details on the size of the stake, any related agreements, and whether the acquisition aligns with the company’s strategic objectives.

Conclusion

Riddhi Siddhi Gluco Biols Ltd has formally notified the market of a substantial share acquisition in Vital Connections LLP through a SEBI Regulation 29(2) filing on 25 June 2026. The notice does not reveal the size of the stake or the financial terms, and further disclosures are expected if the transaction progresses. Until more information is released, the filing serves primarily as a regulatory compliance update.